In the BioHarmony Drug Report Database
Tiludronate
Skelid (tiludronic acid) is a small molecule pharmaceutical. Tiludronic acid was first approved as Skelid on 1997-03-07. It is known to target 72 kDa type IV collagenase.
Trade Name
|
Skelid |
|---|---|
Common Name
|
tiludronic acid |
ChEMBL ID
|
CHEMBL1350 |
Indication
|
|
Drug Class
|
Calcium metabolism regulators |
Image (chem structure or protein)